Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
accredited, ADC, affiliate, amenorrhea, ATM, belamaf, blue, cell, certiorari, cloud, coincided, Comparison, component, Confirmed, contrary, count, Cowen, cyber, cybersecurity, cytotoxic, deadline, deposit, destruction, destructive, diarrhea, director, electrical, excise, exhibited, fatigue, functioning, gathering, gender, GGL, Glaxo, granulosa, inadequacy, interdependent, judgement, mafodotin, malfeasance, median, menopause, mobile, moratorium, nausea, occasion, par, percent, PhRMA, posture, premature, prespecified, PRO, pushed, ransomware, resale, shareholder, sky, software, subtype, supplement, Supplemental, surgery, talent, terrorism, theft, timepoint, unanimously, undetected, unlawful, virtual, writ
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view